News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Endovalve Begins Preclinical Animal Testing of its Mitral-Valve Replacement System, Which Demonstrates Key Feasibility Criteria



6/4/2007 5:05:35 PM

SAN FRANCISCO--(BUSINESS WIRE)--Endovalve, Inc., a cardiovascular device company developing the first percutaneous valve-replacement system to treat mitral regurgitation, today announced that it has developed a to-scale functional model of the valve and anchor design, successfully demonstrated important feasibility criteria and begun preclinical animal testing.

Read at BioSpace.com


comments powered by Disqus
Endovalve
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES